These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 25907232)
41. Risk identification and possible countermeasures for muscle adverse effects during statin therapy. Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999 [TBL] [Abstract][Full Text] [Related]
42. Statin-induced myopathy: a review and update. Abd TT; Jacobson TA Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078 [TBL] [Abstract][Full Text] [Related]
43. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
44. Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance. Li JJ; Dou KF; Zhou ZG; Zhao D; Ye P; Chen H; Chen ZY; Peng DQ; Guo YL; Wu NQ; Qian J; Clin Pharmacol Ther; 2024 May; 115(5):954-964. PubMed ID: 38459425 [TBL] [Abstract][Full Text] [Related]
45. Addressing statin adverse effects in the clinic: the 5 Ms. Katz DH; Intwala SS; Stone NJ J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611 [TBL] [Abstract][Full Text] [Related]
46. An assessment by the Statin Muscle Safety Task Force: 2014 update. Rosenson RS; Baker SK; Jacobson TA; Kopecky SL; Parker BA; The National Lipid Association's Muscle Safety Expert Panel J Clin Lipidol; 2014; 8(3 Suppl):S58-71. PubMed ID: 24793443 [TBL] [Abstract][Full Text] [Related]
47. [Statin myopathy--rarity or reality?]. Pella D Vnitr Lek; 2010 Sep; 56(9 Suppl):972-6. PubMed ID: 21137170 [TBL] [Abstract][Full Text] [Related]
53. Advances in the management of statin myopathy. Gallo A; Perregaux J; Bruckert E Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129 [TBL] [Abstract][Full Text] [Related]
54. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? Sahebkar A; Saboni N; Pirro M; Banach M J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):19-24. PubMed ID: 27897416 [TBL] [Abstract][Full Text] [Related]
55. Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report. Okeahialam BN Vasc Health Risk Manag; 2015; 11():579-81. PubMed ID: 26604775 [TBL] [Abstract][Full Text] [Related]
56. [Statin-induced adverse effects -- facts and genes]. Harangi M; Zsíros N; Juhász L; Paragh G Orv Hetil; 2013 Jan; 154(3):83-92. PubMed ID: 23315223 [TBL] [Abstract][Full Text] [Related]
57. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings. Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960 [TBL] [Abstract][Full Text] [Related]
58. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis. Irwin JC; Khalesi S; Fenning AS; Vella RK Pharmacol Res; 2018 Feb; 128():264-273. PubMed ID: 28943224 [TBL] [Abstract][Full Text] [Related]